BeiGene total debt 2013–2026What is the debt to equity ratio? Debt to equity is a company's total debt divided by its shareholders' equity: how much it has borrowed for each dollar its owners have in the business.
BeiGene's total debt was 1.15B USD on 30 September 2026, up 12.6% on a year before. At the end of fiscal year 2025 it was 2.00B USD.
Last updated 12 Nov 2026 · Next report 25 Feb 2027
Total debt
Growth
| Fiscal year | Period ending | Total debt | Growth | Cash and short-term investments | Net cash | Debt to equity |
|---|---|---|---|---|---|---|
| Latest quarter | 30 Sept 2026 | 1.15B | +12.63% | 5.78B | 4.63B | 0.20 |
| FY2025 | 31 Dec 2025 | 2.00B | +85.19% | 4.55B | 2.55B | 0.46 |
| FY2024 | 31 Dec 2024 | 1.08B | +16.09% | 2.63B | 1.55B | 0.32 |
| FY2023 | 31 Dec 2023 | 930.19M | +55.89% | 3.17B | 2.24B | 0.26 |
| FY2022 | 31 Dec 2022 | 596.68M | -14.10% | 4.53B | 3.94B | 0.14 |
| FY2021 | 31 Dec 2021 | 694.64M | +23.61% | 6.62B | 5.92B | 0.11 |
| FY2020 | 31 Dec 2020 | 561.96M | +102.62% | 4.65B | 4.09B | 0.15 |
| FY2019 | 31 Dec 2019 | 277.34M | +39.79% | 982.74M | 705.40M | 0.29 |
| FY2018 | 31 Dec 2018 | 198.40M | +20.45% | 1.78B | 1.58B | 0.11 |
| FY2017 | 31 Dec 2017 | 164.72M | +852.99% | 837.52M | 672.80M | 0.24 |
| FY2016 | 31 Dec 2016 | 17.28M | -16.85% | 368.17M | 350.89M | 0.05 |
| FY2015 | 31 Dec 2015 | 20.79M | +50.21% | 100.49M | 79.70M | — |
| FY2014 | 31 Dec 2014 | 13.84M | -49.43% | 44.40M | 30.56M | 0.54 |
| FY2013 | 31 Dec 2013 | 27.36M | — | 3.93M | -23.44M | — |
| Quarter | Period ending | Total debt | Growth on a year before | Cash and short-term investments | Net cash | Debt to equity |
|---|---|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 1.15B | +12.63% | 5.78B | 4.63B | 0.20 |
| Q2 FY2026 | 30 Jun 2026 | 1.14B | +11.46% | 5.10B | 3.95B | 0.22 |
| Q1 FY2026 | 31 Mar 2026 | 1.15B | +15.26% | 4.79B | 3.64B | 0.24 |
| Q4 FY2025 | 31 Dec 2025 | 2.00B | +85.19% | 4.55B | 2.55B | 0.46 |
| Q3 FY2025 | 30 Sept 2025 | 1.02B | -7.40% | 4.04B | 3.02B | 0.25 |
| Q2 FY2025 | 30 Jun 2025 | 1.03B | -5.90% | 2.76B | 1.73B | 0.27 |
| Q1 FY2025 | 31 Mar 2025 | 996.83M | -6.24% | 2.52B | 1.52B | 0.28 |
| Q4 FY2024 | 31 Dec 2024 | 1.08B | +16.09% | 2.63B | 1.55B | 0.32 |
| Q3 FY2024 | 30 Sept 2024 | 1.10B | +89.98% | 2.70B | 1.60B | 0.32 |
| Q2 FY2024 | 30 Jun 2024 | 1.09B | +60.81% | 2.59B | 1.50B | 0.32 |
| Q1 FY2024 | 31 Mar 2024 | 1.06B | +95.00% | 2.79B | 1.73B | 0.32 |
| Q4 FY2023 | 31 Dec 2023 | 930.19M | +55.89% | 3.17B | 2.24B | 0.26 |
| Q3 FY2023 | 30 Sept 2023 | 579.77M | -18.41% | 3.17B | 2.59B | 0.15 |
| Q2 FY2023 | 30 Jun 2023 | 677.81M | +7.14% | 3.52B | 2.84B | 0.18 |
| Q1 FY2023 | 31 Mar 2023 | 545.19M | -18.85% | 3.83B | 3.29B | 0.13 |
| Q4 FY2022 | 31 Dec 2022 | 596.68M | -14.10% | 4.53B | 3.94B | 0.14 |
| Q3 FY2022 | 30 Sept 2022 | 710.58M | +1.58% | 5.07B | 4.36B | 0.15 |
| Q2 FY2022 | 30 Jun 2022 | 632.65M | -7.02% | 5.70B | 5.07B | 0.12 |
| Q1 FY2022 | 31 Mar 2022 | 671.88M | +5.21% | 6.24B | 5.57B | 0.11 |
| Q4 FY2021 | 31 Dec 2021 | 694.64M | +23.61% | 6.62B | 5.92B | 0.11 |
| Q3 FY2021 | 30 Sept 2021 | 699.54M | +187.01% | 3.92B | 3.22B | 0.21 |
| Q2 FY2021 | 30 Jun 2021 | 680.38M | +88.07% | 4.38B | 3.70B | 0.19 |
| Q1 FY2021 | 31 Mar 2021 | 638.62M | +114.26% | 4.81B | 4.17B | 0.16 |
| Q4 FY2020 | 31 Dec 2020 | 561.96M | +102.62% | 4.65B | 4.09B | 0.15 |
| Q3 FY2020 | 30 Sept 2020 | 243.73M | -14.54% | 4.72B | 4.48B | 0.06 |
| Q2 FY2020 | 30 Jun 2020 | 361.77M | +31.37% | 3.15B | 2.79B | 0.14 |
| Q1 FY2020 | 31 Mar 2020 | 298.05M | +10.15% | 3.37B | 3.08B | 0.11 |
| Q4 FY2019 | 31 Dec 2019 | 277.34M | +39.79% | 982.74M | 705.40M | 0.29 |
| Q3 FY2019 | 30 Sept 2019 | 285.21M | +45.54% | 1.23B | 946.71M | 0.22 |
| Q2 FY2019 | 30 Jun 2019 | 275.38M | +31.29% | 1.54B | 1.26B | 0.18 |
| Q1 FY2019 | 31 Mar 2019 | 270.59M | +55.80% | 1.61B | 1.34B | 0.17 |
| Q4 FY2018 | 31 Dec 2018 | 198.40M | +20.45% | 1.78B | 1.58B | 0.11 |
| Q3 FY2018 | 30 Sept 2018 | 195.97M | +23.76% | 2.03B | 1.84B | 0.10 |
| Q2 FY2018 | 30 Jun 2018 | 209.75M | +37.34% | 1.37B | 1.16B | 0.17 |
| Q1 FY2018 | 31 Mar 2018 | 173.68M | +772.59% | 1.46B | 1.29B | 0.13 |
| Q4 FY2017 | 31 Dec 2017 | 164.72M | +852.99% | 837.52M | 672.80M | 0.24 |
| Q3 FY2017 | 30 Sept 2017 | 158.35M | +778.24% | 757.44M | 599.09M | 0.21 |
| Q2 FY2017 | 30 Jun 2017 | 152.73M | +1,347.25% | 407.43M | 254.70M | 0.60 |
| Q1 FY2017 | 31 Mar 2017 | 19.90M | +220.31% | 327.48M | 307.57M | 0.06 |
| Q4 FY2016 | 31 Dec 2016 | 17.28M | -16.85% | 368.17M | 350.89M | 0.05 |
| Q3 FY2016 | 30 Sept 2016 | 18.03M | -12.60% | 203.62M | 185.59M | 0.10 |
| Q2 FY2016 | 30 Jun 2016 | 10.55M | -24.88% | 226.62M | 216.07M | 0.05 |
| Q1 FY2016 | 31 Mar 2016 | 6.21M | — | 247.23M | 241.01M | 0.03 |
| Q4 FY2015 | 31 Dec 2015 | 20.79M | +50.21% | 100.49M | 79.70M | — |
| Q3 FY2015 | 30 Sept 2015 | 20.63M | — | 121.34M | 100.72M | 0.21 |
| Q2 FY2015 | 30 Jun 2015 | 14.05M | — | 126.67M | 112.62M | 0.13 |
| Q1 FY2015 | 31 Mar 2015 | 0.00 | — | 44.40M | 44.40M | 0.00 |
| Q4 FY2014 | 31 Dec 2014 | 13.84M | — | 44.40M | 30.56M | 0.54 |
Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.
Total debt counts commercial paper, term debt and lease liabilities.
See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Free cash flow,Balance sheet
Common questions about BeiGene's debt
Source: Financial Modeling Prep
